Cytokinetics, Inc. (CYTK) Tops Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $69.58 -0.49%
Revenue Growth %: +1,966.3%
Financial Fact:
License revenues from related parties: 53.03M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +1,966.3%
Financial Fact:
License revenues from related parties: 53.03M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Cytokinetics, Inc. (NASDAQ: CYTK) reported Q1 EPS of ($0.13), $0.01 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $1.82 million versus the consensus estimate of $1.06 million.
For earnings history and earnings-related data on Cytokinetics, Inc. (CYTK) click here.
For earnings history and earnings-related data on Cytokinetics, Inc. (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Ready Capital prices $225M in new notes, redeems $350M due 2026
- Element Solutions (ESI) PT Lowered to $47 at UBS, Buy Rating Maintained
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
